首页> 外国专利> Co4B Co4B fusion protein with increased immune response induction ability and vaccine composition for preventing or treating Middle East respiratory syndrome comprising the same as effective component

Co4B Co4B fusion protein with increased immune response induction ability and vaccine composition for preventing or treating Middle East respiratory syndrome comprising the same as effective component

机译:具有增强的免疫应答诱导能力的Co4B Co4B融合蛋白和用于预防或治疗中东呼吸综合症的疫苗组合物

摘要

The present invention relates to a vaccine composition for preventing or treating Middle East Respiratory Syndrome containing the Co4B fusion protein having an increased immune response inducing ability consisting of the amino acid sequence of SEQ ID NO: 2 and the fusion protein as an active ingredient.
机译:本发明涉及一种用于预防或治疗中东呼吸综合症的疫苗组合物,其包含具有增强的免疫应答诱导能力的Co4B融合蛋白,所述Co4B融合蛋白由SEQ ID NO:2的氨基酸序列和所述融合蛋白组成作为活性成分。

著录项

  • 公开/公告号KR20200104198A

    专利类型

  • 公开/公告日2020-09-03

    原文格式PDF

  • 申请/专利权人 전북대학교산학협력단;

    申请/专利号KR20190058067

  • 发明设计人 장용석;김주;

    申请日2019-05-17

  • 分类号A61K39/215;A61K39;A61P31/14;C07K14/005;

  • 国家 KR

  • 入库时间 2022-08-21 11:06:07

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号